Fox Run Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
B
Fox Run Management's NEO Position: Q1 2026 in Review
Fox Run Management sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 11,522 shares — an estimated $135K sold.
Fox Run Management first reported a position in NEO in Q2 2016 and held it in 13 quarters. The position peaked at $832K in Q1 2023. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- Fox Run Management reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
- Fox Run Management sold 11,522 NeoGenomics shares in Q1 2026, an estimated $135K.
- Fox Run Management first reported a position in NeoGenomics in Q2 2016 and held it in 13 quarters.
- Fox Run Management's NeoGenomics position peaked at $832K in Q1 2023.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.